3

PRIMARY DOCUMENT

Company: LEXICON PHARMACEUTICALS, INC.
Filed: January 2, 2025
Period of Report: January 2, 2025
Accession Number: 0001127602-25-000080

View Document ↗ View on SEC.gov ↗